Advertisement
Screener

Harrow, Inc. (HROW) Repayments of Related Party Debt

Harrow, Inc. Repayments of Related Party Debt

Harrow, Inc. (HROW) reported Repayments of Related Party Debt of $281.68 thousand for the 185-month period ending 2013-12-31, per its 10-K filed 2014-03-28.

Discontinued › Cash Flow › Financing Activities

us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2014-03-28

  • Harrow, Inc. repayments of related party debt for the quarter ending 2013-03-31 was $0.00.
  • Harrow, Inc. repayments of related party debt for the quarter ending 2012-03-31 was $0.00.
  • Harrow, Inc. repayments of related party debt for the quarter ending 2011-03-31 was $0.00.
  • Harrow, Inc. repayments of related party debt for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
  • Harrow, Inc. repayments of related party debt for fiscal 2011 was $281.68K.
  • Harrow, Inc. repayments of related party debt for fiscal 2010 was $0.00.
Period endRepayments of Related Party Debt 3 monthRepayments of Related Party Debt 12 monthRepayments of Related Party Debt 161 monthRepayments of Related Party Debt 164 monthRepayments of Related Party Debt 167 monthRepayments of Related Party Debt 170 monthRepayments of Related Party Debt 173 monthRepayments of Related Party Debt 176 monthRepayments of Related Party Debt 182 monthRepayments of Related Party Debt 185 month
2013-12-31$281.68K
10-K · filed 2014-03-28
2013-09-30$281.68K
10-Q · filed 2013-11-06
2013-06-30$281.68K
10-Q · filed 2013-08-14
2013-03-31$0.00
10-Q · filed 2013-05-08
$281.68K
10-Q · filed 2013-05-08
2012-12-31$0.00
10-K · filed 2013-03-18
$281.68K
10-K · filed 2013-03-18
2012-09-30$281.68K
10-Q · filed 2012-11-14
2012-06-30$281.68K
10-Q · filed 2012-08-14
2012-03-31$0.00
10-Q · filed 2013-05-08
$281.68K
10-Q · filed 2012-05-10
2011-12-31$281.68K
10-K · filed 2013-03-18
$281.68K
10-K · filed 2012-02-23
2011-03-31$0.00
10-Q · filed 2012-05-10
2010-12-31$0.00
10-K · filed 2012-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Kardigan, Inc. (KARD)United States$1.346B